Literature DB >> 10414431

The effect of caffeine in animal models of learning and memory.

M E Angelucci1, M A Vital, C Cesário, C R Zadusky, P L Rosalen, C Da Cunha.   

Abstract

In the present investigation we studied the effect of caffeine on memory task inhibitory avoidance and habituation to a new environment. Caffeine impaired retention scores in mice submitted to inhibitory avoidance and habituation when administered 30 min before training at the doses of 10-30 mg/kg. These effects cannot be explained by state-dependency since the administration of caffeine 30 min before the test session did not reverse the effect of pre-training caffeine administration, but can more probably be explained by an impairment in the acquisition or by interference with attentional processes. On the other hand, caffeine improved the inhibitory avoidance (but not habituation) retention scores when administered immediately after the training or 30 min before the test session at the doses of 1-30 mg/kg or 3-10 mg/kg, respectively. These results suggest that caffeine differentially affects the different stages of memory processing and that this effect depends on particularities of the memory task under study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10414431     DOI: 10.1016/s0014-2999(99)00225-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

Review 1.  The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities.

Authors:  Claudio Da Cunha; Miriam Elizabeth Mendes Angelucci; Newton S Canteras; Susan Wonnacott; Reinaldo N Takahashi
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 2.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

3.  Electrophysiological studies of the effects of chronic administration of caffeine on the formation of a conditioned defensive reflex in the common snail.

Authors:  D I Silant'eva; T Kh Gainutdinova; V V Andrianov; Kh L Gainutdinov
Journal:  Neurosci Behav Physiol       Date:  2009-04-02

4.  Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.

Authors:  N Pagnussat; A S Almeida; D M Marques; F Nunes; G C Chenet; P H S Botton; S Mioranzza; C M Loss; R A Cunha; L O Porciúncula
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 5.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

6.  Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.

Authors:  Andrea M Bradford; Kevin M Savage; Declan N C Jones; Mikhail Kalinichev
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

7.  Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.

Authors:  Bing Gong; Ottavio V Vitolo; Fabrizio Trinchese; Shumin Liu; Michael Shelanski; Ottavio Arancio
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

8.  The role of adenosine in Alzheimer's disease.

Authors:  Anisur Rahman
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

9.  Caffeine impairs the acquisition and retention, but not the consolidation of Pavlovian conditioned freezing in mice.

Authors:  Sylvain Dubroqua; Samuel R L Low; Benjamin K Yee; Philipp Singer
Journal:  Psychopharmacology (Berl)       Date:  2014-08-30       Impact factor: 4.530

Review 10.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.